Latest news
OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision - StocktwitsStocktwits · Sat, 08 Aug 2026 07:13:33 GMTOTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal - StocktwitsStocktwits · Fri, 07 Aug 2026 22:28:56 GMTOutlook Therapeutics shares climb after FDA clears LYTENAVA for wet AMD - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTOn 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD - Fierce PharmaFierce Pharma · Mon, 27 Jul 2026 07:00:00 GMTOutlook Therapeutics’ Recently Approved Therapy Could Become Preferred Anti-VEGF Treatment Option In $8.5B US Retina Market, Says BTIG - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTOTLK Stock Jumps Overnight After FDA Approval Of Wet AMD Drug — Analysts See Nearly 300% Upside - TradingViewTradingView · Mon, 27 Jul 2026 06:47:00 GMT